chr11-837363-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_004357.5(CD151):c.456+9G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000584 in 1,611,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00036 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00061 ( 0 hom. )
Consequence
CD151
NM_004357.5 intron
NM_004357.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.334
Genes affected
CD151 (HGNC:1630): (CD151 molecule (Raph blood group)) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins. It is involved in cellular processes including cell adhesion and may regulate integrin trafficking and/or function. This protein enhances cell motility, invasion and metastasis of cancer cells. Multiple alternatively spliced transcript variants that encode the same protein have been described for this gene. [provided by RefSeq, Jul 2008]
POLR2L (HGNC:9199): (RNA polymerase II, I and III subunit L) This gene encodes a subunit of RNA polymerase II, the polymerase responsible for synthesizing messenger RNA in eukaryotes. The product of this gene contains four conserved cysteines characteristic of an atypical zinc-binding domain. Like its counterpart in yeast, this subunit may be shared by the other two DNA-directed RNA polymerases. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 11-837363-G-A is Benign according to our data. Variant chr11-837363-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1547196.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD151 | NM_004357.5 | c.456+9G>A | intron_variant | Intron 6 of 8 | ENST00000397420.9 | NP_004348.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 152112Hom.: 0 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
54
AN:
152112
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000261 AC: 65AN: 249298 AF XY: 0.000200 show subpopulations
GnomAD2 exomes
AF:
AC:
65
AN:
249298
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000608 AC: 887AN: 1459602Hom.: 0 Cov.: 33 AF XY: 0.000587 AC XY: 426AN XY: 726166 show subpopulations
GnomAD4 exome
AF:
AC:
887
AN:
1459602
Hom.:
Cov.:
33
AF XY:
AC XY:
426
AN XY:
726166
Gnomad4 AFR exome
AF:
AC:
8
AN:
33456
Gnomad4 AMR exome
AF:
AC:
4
AN:
44704
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26126
Gnomad4 EAS exome
AF:
AC:
0
AN:
39696
Gnomad4 SAS exome
AF:
AC:
0
AN:
86234
Gnomad4 FIN exome
AF:
AC:
2
AN:
52182
Gnomad4 NFE exome
AF:
AC:
856
AN:
1111110
Gnomad4 Remaining exome
AF:
AC:
17
AN:
60334
Heterozygous variant carriers
0
48
96
145
193
241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000355 AC: 54AN: 152112Hom.: 0 Cov.: 34 AF XY: 0.000350 AC XY: 26AN XY: 74296 show subpopulations
GnomAD4 genome
AF:
AC:
54
AN:
152112
Hom.:
Cov.:
34
AF XY:
AC XY:
26
AN XY:
74296
Gnomad4 AFR
AF:
AC:
0.000217265
AN:
0.000217265
Gnomad4 AMR
AF:
AC:
0
AN:
0
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000646888
AN:
0.000646888
Gnomad4 OTH
AF:
AC:
0.000478927
AN:
0.000478927
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Dec 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Epidermolysis bullosa simplex 7, with nephropathy and deafness;C1867341:RAPH BLOOD GROUP SYSTEM Benign:1
Dec 05, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at